# Taysha Gene Therapies, Inc.: Form 8-K, filed Jun 26, 2024

- Company: [Taysha Gene Therapies, Inc.](/companies/tsha.md) (CIK 1806310)
- Form: 8-K
- Filed: 2024-06-26
- Accepted by EDGAR: Jun 26, 2024, 17:14 ET
- Period: 2024-06-26
- Accession: 0001193125-24-169191
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1806310/000119312524169191/d857341d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1806310/000119312524169191/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1806310/000119312524169191/d857341d8k.htm

Filed Jun 26, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-169191. Last ingested by Listed: Nov 12, 2026, 18:00 ET. No prices; not investment advice.